COVID-19 and the liver: What do we know after six months of the pandemic?
- PMID: 32956871
- PMCID: PMC7500273
- DOI: 10.1016/j.aohep.2020.09.001
COVID-19 and the liver: What do we know after six months of the pandemic?
Abstract
Despite liver injury in patients infected with severe acute respiratory syndrome (SARS) coronavirus (CoV)-2 (SARS-CoV-2) is associated with prolonged hospitalization, and liver dysfunction is mainly described in patients with severe viral disease. How liver abnormalities may affect virus infection is still unknown. Improved understanding of host genetics, lifestyle, underlying comorbidities and adequate follow-up of patients with liver damage are critical in the new scenario of the pandemic virus.
Keywords: COVID-19 comorbidities; COVID-19 symptoms; Liver disease; SARS.
Copyright © 2020 Fundación Clínica Médica Sur, A.C. Published by Elsevier España, S.L.U. All rights reserved.
Conflict of interest statement
There are no conflicts of interest to declare.
References
-
- Grant M.C., Geoghegan L., Arbyn M., Mohammed Z., McGuiness L., Clarke E.L., et al. The prevalence of symptoms in 24,410 adults infected by the novel coronavirus (SARS-CoV-2; COVID-19): a systemic review and meta-analysis of 148 studies from 9 countries. PLoS One. 2020;15 doi: 10.1371/journal.pone.0234765. - DOI - PMC - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
